PharmaCielo Ltd. (TSXV:PCLO)
Canada · Delayed Price · Currency is CAD 0.0900
-0.0100 (-10.00%)
Jun 10, 2026, 1:11 PM EST
PharmaCielo Income Statement
Financials in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 3.48 | 1.54 | 5.31 | 1.95 | 2.65 | |
Revenue Growth (YoY) | 125.70% | -70.96% | 172.93% | -26.71% | 237.26% |
Cost of Revenue | 2.75 | 2.91 | 4.63 | 6.09 | 8.59 |
Gross Profit | 0.73 | -1.37 | 0.68 | -4.15 | -5.93 |
Selling, General & Admin | 5.42 | 8.31 | 11.66 | 19.15 | 32.6 |
Depreciation & Amortization Expenses | 0.21 | 0.34 | 0.45 | 1.32 | 1.48 |
Other Operating Expenses | 0.82 | 4.26 | 1.27 | 0.42 | 3.94 |
Total Operating Expenses | 6.45 | 12.91 | 13.38 | 20.89 | 38.01 |
Operating Income | -5.72 | -14.28 | -12.7 | -25.03 | -43.94 |
Interest Income | 0 | 0 | 0 | 0 | 0.07 |
Interest Expense | -3.44 | -2.86 | -1.59 | -0.56 | -0.27 |
Other Non-Operating Income (Expense) | -0.34 | -0.12 | -1.73 | -0.07 | -1.1 |
Total Non-Operating Income (Expense) | -3.79 | -2.98 | -3.32 | -0.63 | -1.31 |
Pretax Income | -9.51 | -17.26 | -16.03 | -25.66 | -45.25 |
Net Income | -9.51 | -16.3 | -14.52 | -26.63 | -43.76 |
Net Income to Common | -9.51 | -16.3 | -14.52 | -26.63 | -43.76 |
Shares Outstanding (Basic) | 176 | 160 | 151 | 146 | 113 |
Shares Outstanding (Diluted) | 176 | 160 | 151 | 146 | 113 |
Shares Change (YoY) | 9.77% | 6.03% | 3.67% | 29.41% | 17.17% |
EPS (Basic) | -0.05 | -0.10 | -0.10 | -0.18 | -0.39 |
EPS (Diluted) | -0.05 | -0.10 | -0.10 | -0.18 | -0.39 |
Shares Outstanding | 175.73 | 169.14 | 154.96 | 149.27 | 138.75 |
Free Cash Flow | -1.97 | -5.17 | -10.4 | -21.21 | -28 |
Free Cash Flow Per Share | -0.01 | -0.03 | -0.07 | -0.15 | -0.25 |
Gross Margin | 21.00% | -88.78% | 12.83% | -213.23% | -223.51% |
Operating Margin | -164.44% | -926.05% | -239.28% | -1287.03% | -1655.77% |
Profit Margin | -273.26% | -1057.09% | -273.45% | -1369.14% | -1648.73% |
FCF Margin | -56.59% | -335.01% | -195.86% | -1090.55% | -1054.97% |
EBITDA | -4.46 | -12.86 | -11.12 | -23.78 | -42.38 |
EBITDA Margin | -128.09% | -834.31% | -209.53% | -1222.43% | -1596.75% |
EBIT | -5.72 | -14.28 | -12.7 | -25.03 | -43.94 |
EBIT Margin | -164.44% | -926.05% | -239.28% | -1287.03% | -1655.77% |